Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi to Sell Its Own Generic Version of Plavix, La Lettre Says
Bloomberg
Monday, October 5, 2009 - 10:35am
tags:
Plavix, Sanofi, generics, Winthrop Pharmaceuticals
Boehringer Sees ‘Uphill Battle’ With Merck, Astra in Diabetes
Bloomberg
Monday, October 5, 2009 - 10:32am
tags:
Boehringer Ingelheim, diabetes, Merck, AstraZeneca, linagliptin
Glaxo reports positive Phase 2 PHN drug study
Marketwatch
Monday, October 5, 2009 - 10:24am
tags:
GSK, neuropathic pain, drug studies
As TV Drug Ads Increase, So Do Concerns
MSN
Sunday, October 4, 2009 - 11:34am
tags:
drug ads
Capital Markets Open Up to Biotechs
Seeking Alpha
Sunday, October 4, 2009 - 11:32am
tags:
biotech
Addrenex Pharmaceuticals Files SNDA Submission For Clonicel To Treat ADHD
Medical News Today
Sunday, October 4, 2009 - 11:30am
tags:
Addrenex, Clonicel, ADHD
Downturn threatens biotechs' viability
San Diego Union Tribune
Sunday, October 4, 2009 - 11:27am
tags:
biotech
FDA tells doctors new heparin formula less potent
WFMJ
Sunday, October 4, 2009 - 11:26am
tags:
Heparin, FDA
China Biotech Week in Review: Wyeth / Pfizer Merger Allowed
Seeking Alpha
Sunday, October 4, 2009 - 11:22am
tags:
China
GE CEO Immelt: Misdirected on Healthcare
Seeking Alpha
Sunday, October 4, 2009 - 11:19am
tags:
GE, India
Mylan gets US FDA nod for generic version of Parkinson's treatment Sinemet
Pharmabiz
Saturday, October 3, 2009 - 10:52am
tags:
Mylan, Sinemet, Parkinson's Disease
NeoPharm: A Pipeline with Multiple Catalysts
One Med Place
Saturday, October 3, 2009 - 10:45am
tags:
NeoPharm
Abbott Keeps Dealing With Solvay Purchase
Yahoo/Investor's Business Daily
Saturday, October 3, 2009 - 10:08am
tags:
Abbott Laboratories, Solvay
Warning: Potential Blockbuster Ahead
Motley Fool
Saturday, October 3, 2009 - 9:40am
tags:
Bristol-Myers Squibb, AstraZeneca, Dapagliflozin, type 2 diabetes
AstraZeneca: Nektar Deal to Add Value
Yahoo/Zacks
Saturday, October 3, 2009 - 9:37am
tags:
AstraZeneca, Nektar
Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease
Yahoo/PR NewsWire
Saturday, October 3, 2009 - 9:35am
tags:
Pilcera, Gaucher disease, Amicus Therapeutics
BioCryst Clarifies Government Declaration Regarding Peramivir
Yahoo/PR NewsWire
Saturday, October 3, 2009 - 9:34am
tags:
peramivir, Biocryst
Drug stocks trade little changed; QLT rallies on sale
MarketWatch
Saturday, October 3, 2009 - 9:33am
tags:
QLT
NASDAQ warns Targeted Genetics, extension given
bizjournals.com
Saturday, October 3, 2009 - 9:30am
tags:
Targeted Genetics
Discovery Labs: Pump Up the Volume
The Street
Saturday, October 3, 2009 - 9:27am
tags:
Discovery Labs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.